US FDA’s Advanced Manufacturing Designation Lifts Off With Cellares Cell Shuttle

Cellares’ fully automated cell therapy manufacturing platform is the first system to receive an Advanced Manufacturing Technology designation from US FDA

Cellares hopes its Cell Shuttle will ride an Advanced Manufacturing Technology designation to new corporate heights (Shutterstock)
Key Takeaways
  • Cellares’ Cell Shuttle, an automated manufacturing platform for cell therapy, is the first system to receive an Advanced Manufacturing Technology designation from the FDA

Cellares became the first company to announce receipt of an Advanced Manufacturing Technology designation from the US FDA on 1...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Platform Technologies

More from Compliance